Moleculin Biotech Inc at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (Virtual) Transcript
This is Susan Chor from Oppenheimer. I will be covering for Kevin DeGeeter. I want to thank everyone for joining us this afternoon. We have Wally, CEO of Moleculin, to present and take questions. Just as a reminder, please submit questions in the text box. And without further ado, Wally, please begin.
Thanks, Susan. And hello, everyone. Again I am Wally Klemp, Co-Founder, Chairman and CEO of Moleculin Biotech, Inc. We do appreciate the opportunity to present at this conference. And we hope you find this information to be helpful.
Moleculin is a NASDAQ-listed company trading under the ticker symbol MBRX, and as such, we do need to make some important disclaimers about the presentation. You can review these disclaimers along with the rest of this presentation at your convenience by visiting the Investors section of our website at moleculin.com.
We built this Company around three core technologies that all originated at
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |